Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
Dow 12,938.70 -27.02 -0.21%
S&P 500 1,357.66 -4.55 -0.33%
Nasdaq 2,933.17 -15.40 -0.52%
Ticker Volume Price Price Delta
STOXX 50 2,519.00 -22.60 -0.89%
FTSE 100 5,916.55 -11.65 -0.20%
DAX 6,843.87 -64.31 -0.93%
Ticker Volume Price Price Delta
Nikkei 9,548.51 -5.49 -0.06%
TOPIX 824.34 -1.06 -0.13%
Hang Seng 21,372.70 -176.62 -0.82%
Gold 1,775.10 +0.21%
EUR-USD 1.3248 -0.0090%
Nasdaq 2,933.17 -0.52%
Dow 12,938.70 -0.21%
S&P 500 1,357.66 -0.33%
FTSE 100 5,916.55 -0.20%
STOXX 50 2,519.00 -0.89%
DAX 6,843.87 -0.93%
Oil (WTI) 105.76 -0.49%
U.S. 10-year 2.016% -0.044
BAC:US 7.95 -1.97%
8411:JP 130.00 0.00%
Live TV
  • Exchange: Tokyo
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Takeda Pharmaceutical Co Ltd

Add to Portfolio

4502:JP

3,590 JPY 30 0.84%

As of 21:16:46 ET on 02/22/2012.

Snapshot for Takeda Pharmaceutical Co Ltd (4502)

Open: 3,590 Day's Range: 3,580 - 3,600 Volume: 1,508,800 Bid: 3,585
Previous Close: 3,560 52wk Range: 3,005 - 4,105 1-Yr Rtn: -7.07% Ask: 3,590

Stock Chart for 4502

No chart data available.
  • 4502:JP 3,590
  • 1D
  • 1M
  • 1Y
3,560
Interactive Chart

Previous Close

Key Statistics for 4502

Current P/E Ratio (ttm) 11.8417
Estimated P/E (03/2012) 13.1894
Earnings Per Share (JPY) (ttm) 303.1650
Est. EPS (JPY) (03/2012) 272.1890
Est. PEG Ratio -
Market Cap (M JPY) 2,834,901.25
Shares Outstanding (M) 789.67
Enterprise Value (M JPY) (ttm) 3,049,440.28
Enterprise Value/EBITDA (ttm) 7.02
Price/Book (mrq) 1.4257
Price/Sale (ttm) 2.0129
Dividend Yield (JPY) (ttm) 5.0139
Next Earnings Announcement 05/11/2012
More 4502 Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for 4502

No data available.
  • Revenue
  • Net Income (M/)
  • Profit Margin (%)
More Financials Data
  • Total Assets
  • Total Liabilities (M/)
  • Debt to Assets (%)
More Financials Data
  • Operating
  • Investing
  • Financing (M/)
More Financials Data

Company Profile & Key Executives for 4502

Takeda Pharmaceutical Company Limited mainly manufactures and sells pharmaceuticals, food supplements, and chemical products like polyurethane. The Company also produces food, agrochemicals, and environment-related products such as pollution detectors. Takeda Pharmaceutical researches, develops, and promotes the products through its related companies in the US, Europe, and Asia.

Yasuchika HasegawaPRESIDENT/CEOToyoji YoshidaCAO/MANAGING DIRECTOR
Shigenori OhkawaCHIEF SCIENTIFIC OFCR/DIRECTORYasuhiko YamanakaMANAGING DIRECTOR
More Company Profile & Key Executives for 4502

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements